Basel Medical (BMGL) Common Equity (2024 - 2025)
Basel Medical recorded quarterly Common Equity of $4.2 million in Q2 2025, down 21.4% quarter-over-quarter from $5.3 million in Q4 2024, and down 25.25% year-over-year from $5.6 million in Q2 2024.
Basel Medical's Common Equity history runs 2 years deep, the most recent figure standing at $4.2 million for Q2 2025.
- In Q2 2025, Common Equity fell 25.25% year-over-year to $4.2 million; the TTM figure through Jun 2025 stood at $4.2 million (down 25.25% YoY), while the FY2025 annual figure was $4.3 million, down 23.5% from the prior year.
- Common Equity came in at $4.2 million for Q2 2025 at Basel Medical, down from $5.3 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $5.6 million in Q2 2024 to a low of $4.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 84.64 Bn | 87.02 Bn | 16.26 Bn | -2.98 Bn |
| 2 | Tenet Healthcare | 15.22 Bn | 14.39 Bn | 4.41 Bn | 4.81 Bn |
| 3 | Davita | 13.10 Bn | 13.96 Bn | 1.07 Bn | -476.34 Mn |
| 4 | Encompass Health | 10.50 Bn | 11.12 Bn | 1.34 Bn | 3.31 Bn |
| 5 | Ensign | 9.69 Bn | 9.09 Bn | 293.37 Mn | 2.37 Bn |
| 6 | Universal Health Services | 8.92 Bn | 8.88 Bn | 3.21 Bn | 7.46 Bn |
| 7 | Fresenius Medical Care AG | 7.31 Bn | 4.93 Bn | 22,843.10 Bn | 16.63 Bn |
| 8 | Chemed | 5.83 Bn | 5.81 Bn | 215.76 Mn | 847.99 Mn |
| 9 | Pacs | 5.76 Bn | 5.51 Bn | 345.96 Mn | 1.04 Bn |
| 10 | Basel Medical | 8.57 Mn | 6.23 Mn | - | 4.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 4.18 Mn |
| Dec 31, 2024 | 5.32 Mn |
| Jun 30, 2024 | 5.59 Mn |